These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 31682129)

  • 1. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K; Delaney S; Zhang GGZ; Munson EJ
    Mol Pharm; 2019 Dec; 16(12):4836-4851. PubMed ID: 31682129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions.
    Sarpal K; Munson EJ
    J Pharm Sci; 2021 Apr; 110(4):1457-1469. PubMed ID: 33359813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.
    Yuan X; Xiang TX; Anderson BD; Munson EJ
    Mol Pharm; 2015 Dec; 12(12):4518-28. PubMed ID: 26512737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
    Konno H; Taylor LS
    J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
    Liu L; Chen L; Müllers W; Serno P; Qian F
    Mol Pharm; 2022 Aug; 19(8):2888-2899. PubMed ID: 35759395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion.
    Song Y; Wang L; Yang P; Wenslow RM; Tan B; Zhang H; Deng Z
    J Pharm Sci; 2013 Jun; 102(6):1915-1923. PubMed ID: 23580396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the influence of hydrogen bond donor groups on the microstructure and intermolecular interactions of amorphous solid dispersions containing diflunisal structural analogues.
    Cools L; Derveaux E; Reniers F; Dehaen W; Adriaensens P; Van den Mooter G
    Int J Pharm; 2024 Aug; 661():124438. PubMed ID: 38972518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
    Sarpal K; Tower CW; Munson EJ
    Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of solid-state
    Ueda K; Okada H; Zhao Z; Higashi K; Moribe K
    Int J Pharm; 2020 May; 581():119300. PubMed ID: 32268185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
    Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
    Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
    Giannachi C; Allen E; Egan G; Vucen S; Crean A
    Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solvent influence on manufacturability, phase behavior and morphology of amorphous solid dispersions prepared via bead coating.
    Boel E; Giacomini F; Van den Mooter G
    Eur J Pharm Biopharm; 2021 Oct; 167():175-188. PubMed ID: 34325003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
    Mistry P; Mohapatra S; Gopinath T; Vogt FG; Suryanarayanan R
    Mol Pharm; 2015 Sep; 12(9):3339-50. PubMed ID: 26070543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.
    Donnelly C; Tian Y; Potter C; Jones DS; Andrews GP
    Pharm Res; 2015 Jan; 32(1):167-79. PubMed ID: 25074468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
    Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H; Taylor LS
    Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.